Extending access for breast cancer, and epidu...

The class of GLP-1 agonist drugs including Ozempic gained a wide reputation for weight loss in 2025. However, it's well established that weight regain is a common result after people stop their doses. We report on new research which aims to quantify what is happening in the here- ...  Show more

This episode is available in video form on YouTube: https://youtu.be/1cGrD47eZSk American science fiction author Kim Stanley Robinson joins Kamran Abbasi to discuss climate disaster, the need for political imagination, and science fiction's vision for health. Kim Stanley Robinson ...  Show more

There’s a whirlwind of emotions that comes with a breast cancer diagnosis. But it doesn’t have to be a punishment.  Integrative Oncologist Dr. Jenn Simmons works as a breast cancer expert to help thousands of women see their breast cancer diagnosis as an opportunity to reclaim t ...  Show more

Today I am speaking with Dr. Jenn Simmons, MD on all things breast cancer, breast cancer prevention and treatment.

About Dr. Jenn

Integrative Oncologist, Author, Podcast Host, and the founder of PerfeQTion Imaging He ...

There continues to be great confusion regarding the impact of hormone therapy on the breast. And despite the known benefits of hormone therapy, and reassuring data regarding the impact of hormone therapy on breast cancer, most clinicians are still reluctant to prescribe it, and m ...  Show more

There's a reliable indicator of a woman's future likelihood of cardiovascular disease — but it rarely gets asked about, says obstetrician and researcher Meryam Sugulle. She delves into the role of the placenta in pregnancy, how it can predict health outcomes and the single que ...